Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 1
2013 2
2014 3
2015 1
2017 4
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Polio endgame: the global introduction of inactivated polio vaccine.
Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M. Patel M, et al. Among authors: zipursky s. Expert Rev Vaccines. 2015 May;14(5):749-62. doi: 10.1586/14760584.2015.1001750. Epub 2015 Jan 19. Expert Rev Vaccines. 2015. PMID: 25597843 Review.
nOPV2 development as a global effort for polio outbreak response.
Bandyopadhyay AS, Zipursky S. Bandyopadhyay AS, et al. Among authors: zipursky s. Lancet Glob Health. 2023 Nov;11(11):e1695. doi: 10.1016/S2214-109X(23)00375-3. Lancet Glob Health. 2023. PMID: 37858579 Free article. No abstract available.
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Macklin GR, Peak C, Eisenhawer M, Kurji F, Mach O, Konz J, Gast C, Bachtiar NS, Bandyopadhyay AS, Zipursky S; nOPV2 Working Group. Macklin GR, et al. Among authors: zipursky s. Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A122-A127. doi: 10.1016/j.vaccine.2022.02.050. Epub 2022 Mar 17. Vaccine. 2023. PMID: 35307230 Free PMC article.
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
Martin J, Burns CC, Jorba J, Shulman LM, Macadam A, Klapsa D, Majumdar M, Bullows J, Frolov A, Mate R, Bujaki E, Castro CJ, Bullard K, Konz J, Hawes K, Gauld J, Blake IM, Mercer LD, Kurji F, Voorman A, Diop OM, Oberste MS, Modlin J, Macklin G, Eisenhawer M, Bandyopadhyay AS, Zipursky S. Martin J, et al. Among authors: zipursky s. MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):786-790. doi: 10.15585/mmwr.mm7124a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35709073 Free article.
Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023.
Davlantes E, Jorba J, Henderson E, Bullard K, Deka MA, Kfutwah A, Martin J, Bessaud M, Shulman LM, Hawes K, Diop OM, Bandyopadhyay AS, Zipursky S, Burns CC. Davlantes E, et al. Among authors: zipursky s. MMWR Morb Mortal Wkly Rep. 2023 Sep 22;72(38):1041-1042. doi: 10.15585/mmwr.mm7238a4. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37733626 Free PMC article. No abstract available.
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
Harutyunyan V, Quddus A, Pallansch M, Zipursky S, Woods D, Ottosen A, Vertefeuille J, Lewis I. Harutyunyan V, et al. Among authors: zipursky s. Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A70-A78. doi: 10.1016/j.vaccine.2022.02.058. Epub 2022 Mar 10. Vaccine. 2023. PMID: 35282924 Free PMC article.
21 results